 |
|
Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates
Tae Hoon Eom, Young-Hoon Kim
Clin Exp Pediatr. 2024;67(1):26-34. Published online 2023 Jun 14 DOI: https://doi.org/10.3345/cep.2021.01466
|
|
Citations to this article as recorded by
 Atomoxetine Treatment of Attention Deficit/Hyperactivity Disorder Symptoms in 3–6-Year-Old Children with Autism Spectrum Disorder: A Retrospective Cohort Study
Hamza A. Alsayouf, Osama Alsarhan, Wael Khreisat, Azhar Daoud
Children.2024; 11(2): 163. CrossRef Attention-deficit/hyperactivity disorder: clinical phenotypes, polymorphism of life-course manifestations, and therapeutic strategies
I. Martsenkovsky, I. Martsenkovska, H. Makarenko
INTERNATIONAL NEUROLOGICAL JOURNAL.2024; 20(2): 57. CrossRef Screening tools for adult ADHD patients in primary care
Johanna Louise Ganzenmüller, Cora Ballmann, Regina Margarethe Wehrstedt von Nessen-Lapp, Marcel Schulze, Linda Sanftenberg, Mathias Berger, Alexandra Philipsen, Jochen Gensichen
Journal of Affective Disorders Reports.2024; 17: 100800. CrossRef Growing evidence of pharmacotherapy effectiveness in managing attention-deficit/hyperactivity disorder in young children with or without autism spectrum disorder: a minireview
Hamza A. Alsayouf
Frontiers in Psychiatry.2024;[Epub] CrossRef Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases
Hubertus Himmerich, Jessica Bentley, Susan L. McElroy
CNS Drugs.2024; 38(9): 697. CrossRef
|